Phytomedics Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Phytomedics Inc.
Finance Watch: Neuron23 Adds $100m To Take First Drug Into The Clinic
Private Company Edition: Westlake Village BioPartners-founded Neuron23 will take the LRRK2 inhibitor NEU-723 for Parkinson’s disease into human testing before the end of 2022. Also, Celsius raised $83m in fresh VC cash and ITM added another €33m to its recent €25m equity financing.
Minute Insight: Biotronik Launches Remote Monitor That Can Prevent Heart Failure Hospitalizations
The HeartInsight algorithm combines heart failure parameters into a predictive score and alerts physicians if a patient with an implanted ICD or CRT-D is at higher risk of hospitalization. Biotronik will roll out HeartInsight in Europe in April.
Keeping Track: Spectrum Submits Poziotinib; US FDA Approves Daré’s Xaciato, Expands Heron Zynrelef Label
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Listen Up! Big Things Happening In The World Of Audiology
From innovation to legislation, the US audiology market is being shaped by cutting-edge technology from device makers and legislation from the Biden administration to get more hearing aids to those that need them.
Company Information
- Industry
-
Pharmaceuticals
- Nutraceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity